Invesaro

Stocks PDYN Financial statements

Financial statements

Palladyne AI Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Palladyne AI Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2021FY2022FY2023FY2024FY2025
Revenue8.815.0814.66.157.795.25
Cost of revenue5.63.8711.65.043.492.69
Gross profit3.211.212.961.114.32.56
Research and development14.117.534.13910.412.9
Selling and marketing2.86.629.9510.84.134.74
General and administrative7.358.163.531.516.817.2
Operating income-21-81-177-121-26.9-32.4
Other non-operating income0.030.050.741.9100.22
Pre-tax income-20.9-81.5-161-116-72.67.5
Income tax00-3.890.010.01-2.54
Net income-20.9-81.5-157-116-72.610
EBITDA-20.5-80.5-176-119-26.1-31.4
EPS, basic-1.26-4.32-6.42-4.51-2.710.26
EPS, diluted-1.26-4.32-6.42-4.51-2.710.24
Shares, basic (weighted)16.718.924.525.626.838.8
Shares, diluted (weighted)16.718.924.525.626.842.1

Balance sheet

FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents33.721735.223.131.218.2
Short-term investments79.315.98.8828.8
Receivables1.050.791.870.560.131.06
Inventory0.711.013.561.070.070.34
Other current assets0.699.25.022.321.281.65
Total current assets36.322812945.142.752.6
Property, plant and equipment1.437.057.644.844.248.89
Lease right-of-use assets11.310.18.848.65
Goodwill014.7
Intangible assets19.1010.4
Other non-current assets0.290.440.490.430.440.46
Total assets38.123616860.456.395.7
Accounts payable0.971.683.621.290.441.06
Accrued liabilities1.264.486.035.812.923.55
Deferred revenue0.080.250.32
Total current liabilities3.566.1610.58.464.435.67
Long-term debt1.07
Lease liabilities12.4119.969.73
Other non-current liabilities0.5315.70.260.0302.87
Total liabilities5.1521.923.219.565.821
Paid-in capital96.9359447459481555
Retained earnings-64-145-303-418-491-481
Other comprehensive income-0.0200.010.01
Shareholders' equity32.921414440.9-9.5374.7
Minority interests-0
Total equity32.921414440.9-9.5374.7
Total liabilities and equity38.123616860.456.395.7
Shares outstanding17.32325.725.933.946.1

Cash flow statement

FY2020FY2021FY2022FY2023FY2024FY2025
Net income-20.9-81.5-157-116-72.610
Depreciation and amortization0.460.531.411.550.830.97
Stock-based compensation2.2943.135.6122.814.45
Deferred income tax0-3.90-2.54
Change in receivables-0.140.26-0.261.310.141.1
Change in inventory0.44-0.3-2.09-8.760.990.06
Change in payables-0.320.241.54-2.33-0.82-0.71
Cash from operations-16.9-42.1-65.4-76.6-22.6-27.6
Capital expenditures-0.95-4.69-1.5-0.78-0.27-0.71
Acquisitions-29.70-5.3
Purchases of investments-178-64.5-8.86-75.6
Sales and maturities of investments1001301657
Cash from investing-0.95-4.69-10964.76.88-24.6
Debt repaid0-3.7
Stock issued0.120.030.6802036.4
Cash from financing42.3230-7.52-0.0823.839.2
Net change in cash24.5183-182-128.05-13
Free cash flow-17.8-46.8-66.9-77.4-22.9-28.4
Interest paid00.010.01
Income taxes paid000.010.010

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.39 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin28.7%Gross profit / revenue.
Operating margin-360.7%Operating income / revenue.
EBITDA margin-349.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-276.2%Pre-tax income / revenue.
Net margin-254.7%Net income / revenue.
FCF margin-310.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-297.2%Cash from operations / revenue.
Return on equity (ROE)-42.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-32.0%Net income / average total assets.
Return on invested capital (ROIC)-91.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue127.8%Research and development expense / revenue.
Stock-based pay / revenue48.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue12.7%Capital expenditures / revenue.
D&A / revenue11.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-32.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-28.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-9.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-40.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-4.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-4.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value CAGR, 3y-19.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y17.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y70.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-17.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y20.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y57.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y19.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y20.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio6.30xCurrent assets / current liabilities.
Quick ratio5.58x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio5.30x(Cash + short-term investments) / current liabilities.
Liabilities / assets24.9%Total liabilities / total assets.
Working capital$43.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets25.9%(Goodwill + intangible assets) / total assets.
Tangible book value$46.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.13xRevenue / average total assets.
Fixed asset turnover1.31xRevenue / average property, plant and equipment.
Inventory turnover8.98xCost of revenue / average inventory.
Days inventory41 days365 x average inventory / cost of revenue.
Receivables turnover5.12xRevenue / average receivables.
Days sales outstanding71 days365 x average receivables / revenue.
Days payables52 days365 x average accounts payable / cost of revenue.
Cash conversion cycle60 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.66Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.26Revenue / diluted weighted shares.
FCF per share-$0.80Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.77Cash from operations / diluted weighted shares.
Book value per share$1.44Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.94Tangible book value / shares outstanding.
Cash per share$0.89(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$265.9MShare price x shares outstanding.
Enterprise value$222.2MMarket cap + total debt - cash - short-term investments.
P/S22.5xMarket cap / revenue.
P/B3.75xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book5.73xMarket cap / tangible book value, when positive.
EV/Sales18.8xEnterprise value / revenue.
FCF yield-13.8%Free cash flow / market cap.
Earnings yield-11.3%Net income / market cap (the inverse of P/E).
What was Palladyne AI Corp.'s revenue in fiscal 2025?

Palladyne AI Corp. reported revenue of $5.2M for fiscal 2025, 32.6% lower than the year before.

Was Palladyne AI Corp. profitable in fiscal 2025?

Yes. Net income was $10.0M, a net margin of 191.4%.

How much free cash flow did Palladyne AI Corp. generate in fiscal 2025?

Cash from operations of $27.6M minus capital expenditures of $713.0K left free cash flow of -$28.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Palladyne AI Corp.